# Standard Biotools Inc.: Form 8-K, filed Mar 18, 2024

- Company: [Standard Biotools Inc.](/companies/lab.md) (CIK 1162194)
- Form: 8-K
- Filed: 2024-03-18
- Accepted by EDGAR: Mar 18, 2024, 09:14 ET
- Period: 2024-03-18
- Accession: 0001104659-24-035297
- Inline XBRL: yes
- Main document: https://www.sec.gov/Archives/edgar/data/1162194/000110465924035297/tm249061d1_8k.htm
- All documents and exhibits: https://www.sec.gov/Archives/edgar/data/1162194/000110465924035297/

## Items reported

- Item 1.01: Entry into a material agreement
- Item 3.02: Unregistered sale of equity
- Item 5.02: Departure or appointment of officers or directors
- Item 5.03: Amendment to articles or bylaws
- Item 7.01: Regulation FD disclosure
- Item 9.01: Financial statements and exhibits

## Sections

Sections are extracted only from 10-K and 10-Q reports. Read this filing’s documents on sec.gov. https://www.sec.gov/Archives/edgar/data/1162194/000110465924035297/tm249061d1_8k.htm

Filed Mar 18, 2024.
Source: SEC EDGAR, the filing index for accession 0001104659-24-035297. Last ingested by Listed: Nov 5, 2026, 21:16 ET. No prices; not investment advice.